depatuxizumab mafodotin

Ligand id: 7970

Name: depatuxizumab mafodotin

Compound class Antibody
International Nonproprietary Names
INN number INN
10263 depatuxizumab mafodotin
Depatuxizumab mafodotin (ABT-414) is an antibody-drug conjugate (ADC), which targets a unique tomour-specific EGFR epitope in some cancer cells [5]. The antibody portion recognises EGFR in glioblastoma cells with EGFR gene amplification or expressing the truncated Δ2-7 EGFR mutant (aka EGFRvIII) [2-3]. The antibody is linked to the cytotoxic agent, monomethyl auristatin F (MMAF; PubChem CID 56841603) (information derived from Phillips et al. (2013) [4] and Abbvie's webpage for oncology pipeline compounds and references therein [1].
Database Links
GtoPdb PubChem SID 249565653
Search PubMed clinical trials depatuxizumab mafodotin
Search PubMed titles depatuxizumab mafodotin
Search PubMed titles/abstracts depatuxizumab mafodotin